Nearly 3 years after passage of the Physician Payments Sunshine Act, the Centers for Medicare & Medicaid Services (CMS) released its final rule intended to increase public awareness of financial relationships between drug and device manufacturers and certain health care practitioners.
The “National Physician Payment Transparency Program: Open Payments” rule, announced February 1, is a part of the Affordable Care Act designed to improve transparency in the health care market. The rule lays out provisions that require manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children's Health Insurance Program to report to CMS any payments or other transfers of value made to physicians and hospitals.
Mitka M. Letting the Sunshine In. JAMA. 2013;309(10):973. doi:10.1001/jama.2013.1716
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.